WHO ICTRP trial

SerTRaline for AnxieTy in adults with a diagnosis of Autism (STRATA) A…

ACTRN12621000801819 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12621000801819
Public title SerTRaline for AnxieTy in adults with a diagnosis of Autism (STRATA) A randomised controlled trial.
Scientific title A multicentre double-blind placebo-controlled randomised trial of SerTRaline for AnxieTy in adults with Autism (STRATA)-Australian component.
Primary sponsor The University of Western Australia (UWA)
Secondary sponsors University of Bristol (UoB)
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 4
Countries Australia
Conditions Anxiety;Autism; Anxiety Autism;Mental Health - Anxiety;Mental Health - Autistic spectrum disorders
Interventions The research project is a two parallel group multi-centre pragmatic randomised controlled trial (RCT) of sertraline versus placebo for reducing anxiety in adults with a diagnosis of autism. The active investigational medicinal products are…
Registration date Jun 25, 2021
Target size 75
Secondary IDs Nil known.
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations